Liposyn infusion increases plasma prostaglandin concentrations

Carl E. Hunt*, Lauren M. Pachman, Joseph R. Hageman, Michael A. Cobb, Linda Klemka

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


To determine whether Liposyn infusion results in increased plasma prosta‐glandin (PG) concentrations, the following study was performed in 33 adult rabbits with chronically implanted arterial and venous catheters. Plasma PG concentrations were determined by radioimmunoassay for two vasodilators, PGE2 and PGI2 (as measured by its metabolite 6‐keto‐PGF), and two vasoconstrictors, thromboxane (TX) A2, and PGF, as measured by their metabolites TXB2 and PGF‐M, respectively. A 1‐hour infusion of Liposyn at 4 ml per kg resulted in statistically significant increases in arterial and venous concentrations of PGE2 and 6‐keto‐PGF (p < 0.001) and of TXB, (p < 0.04). There were no significant changes in PGF‐M plasma concentrations. Liposyn infustion also resulted in a small but statistically significant increase in Pao2 of 4.7 ± 1.5 torr (p < 0.01). It is concluded that Liposyn infusion results in statistically significant increases in plasma concentrations of PGE2, 6‐keto‐PGF, and TXB2.

Original languageEnglish (US)
Pages (from-to)154-158
Number of pages5
JournalPediatric Pulmonology
Issue number3
StatePublished - 1986


  • 33 adult rabbits
  • 6‐keto‐PGF
  • Increased plasma concentrations
  • Liposyn infusion
  • PGE
  • TXB

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Liposyn infusion increases plasma prostaglandin concentrations'. Together they form a unique fingerprint.

Cite this